Bio-Techne's Commitment to Sustainability in 2024
Bio-Techne Corporation (NASDAQ: TECH) has released its 2024 Corporate Sustainability Report (CSR), which highlights the company's continuing commitment to advancing Environmental, Social, and Governance (ESG) initiatives. This report reflects their ongoing efforts to create a sustainable environment ingrained in their corporate culture.
Core Pillars of Sustainability
The CSR is organized around four essential pillars: Our People, Advancing Science, Governance and Operational Integrity, and The Environment. These pillars form the basis of Bio-Techne's operations and their interactions with the surrounding world, underscoring their EPIC values: Empowerment, Passion, Innovation, and Collaboration.
Empowering Their Team
The heart of Bio-Techne’s success lies in its dedicated team of professionals. Kim Kelderman, the President and Chief Executive Officer, emphasizes that the company is committed to enriching communities while providing innovative solutions crucial for advancements in science and medicine. Their focus on governance and operational integrity promotes responsible and effective growth.
Sustainability Initiatives in Action
This year’s report showcases notable progress in Bio-Techne's sustainability efforts. Shane Bohnen, the Chief Sustainability Officer, shared key achievements, including their commitment to lowering Scope 1, 2, and 3 greenhouse gas emissions. These goals will undergo rigorous assessment by the Science Based Targets Initiative (SBTI) in the coming years.
EcoVadis Assessment
A significant achievement in their sustainability journey was successfully completing their first EcoVadis sustainability assessment. In this evaluation, Bio-Techne earned a Bronze Medal, placing them within the top 67% of all companies assessed. This recognition highlights their dedication to ethical practices, labor rights, and sustainable procurement.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a leader in life sciences, providing state-of-the-art tools and bioactive reagents that support both research and clinical diagnostic sectors. Their comprehensive array of products plays a critical role in scientific exploration of biological processes and significantly aids in drug discovery and precise clinical diagnoses.
With a diverse portfolio that includes hundreds of thousands of products, Bio-Techne reported around $1.2 billion in net sales during the latest fiscal period, employing approximately 3,100 people globally.
Staying Connected
For more information about Bio-Techne and their wide-ranging offerings, check out their official website. They are also present on social media platforms like Facebook, LinkedIn, Twitter, and YouTube, where they engage with the community and share updates on their latest developments.
Frequently Asked Questions
What is included in the 2024 Corporate Sustainability Report from Bio-Techne?
The report highlights advancements in Environmental, Social, and Governance (ESG) initiatives that Bio-Techne is undertaking.
How does Bio-Techne plan to reduce their greenhouse gas emissions?
Bio-Techne is committed to lowering Scope 1, 2, and 3 emissions, with targets that will be reviewed by the Science Based Targets Initiative (SBTI).
What recognition did Bio-Techne receive for their sustainability efforts?
Bio-Techne received a Bronze Medal in their first EcoVadis sustainability assessment, which placed them in the top 67% of evaluated companies.
How large is Bio-Techne's employee base?
Bio-Techne employs about 3,100 individuals globally, all contributing to its mission in the life sciences sector.
Where can I find more information about Bio-Techne?
You can find additional details on their official website and through their various social media channels.